Recent evidence has been presented that expression of lipogenic genes is down-regulated in adipose tissue of ob/ob mice as well as in human obesity, suggesting a functionally lipoatrophic state. Using 2 H 2 O labeling, we measured three adipose tissue biosynthetic processes concurrently: triglyceride (TG) synthesis, palmitate de novo lipogenesis (DNL), and cell proliferation (adipogenesis). To determine the effect of the ob/ob mutation (leptin deficiency) on these parameters, adipose dynamics were compared in ob/ob, leptin-treated ob/ob, food-restricted ob/ob, and lean control mice. Adipose tissue fluxes for TG synthesis, DNL and adipogenesis were dramatically increased in ob/ob mice compared to lean controls. Low-dose leptin treatment (2 µg/ day) via mini-osmotic pump suppressed all fluxes to control levels or below. Food restriction in ob/ob only modestly reduced DNL with no change in TG synthesis or adipogenesis. Measurement of mRNA levels in age-matched ob/ob mice showed generally normal expression levels for most of the selected lipid anabolic genes and leptin treatment had, with few exceptions, only modest effects on their expression. We conclude that leptin deficiency per se results in marked elevations in flux through diverse lipid anabolic pathways in adipose tissue (DNL, TG synthesis and cell proliferation), independent of food intake, but that gene expression fails to reflect these changes in flux.
Introduction
The ob/ob mouse exhibits obesity, insulin resistance, hyperphagia, sterility and other metabolic and hormonal disturbances, due to a mutation in the leptin gene (23) .
Histological (1) and biochemical evidence (22, 25, 26, 28, 46) suggests that these disturbances include abnormal dynamics of both the lipid and cellular components of adipose tissue.
De novo lipogenesis (DNL) has been well studied in the ob/ob mouse. In vivo 3 H 2 O labeling studies have shown increased hepatic (14, 22, 29) and adipose tissue (6, 14, 22, 29) DNL. Inhibitory effects of leptin on DNL have also been demonstrated (2) .
Triglyceride (TG) synthesis and degradation (lipolysis) can now also be measured in adipose tissue by administration of 2 H 2 O (5, 39, 44). Measurement of TG synthesis contributes another metric of adipose tissue metabolism in vivo, and also allows for more accurate assessment of DNL rates (39) . Generally, DNL is measured as a fraction of total lipid or palmitate present in a lipid sample. By measuring the fraction of new TG from all sources concurrently with the fraction of TG from DNL, the true contribution of DNL to newly synthesized TG can be calculated (39) . We have shown elsewhere that cell proliferation, DNL and TG synthesis can be measured concurrently, using 2 H 2 O labeling (39) .
Leptin has also been shown to inhibit differentiation of preadipocytes (2, 42) , and to reverse the differentiation of mature adipocytes (47) in vitro. These effects on adipocyte differentiation have been proposed to have a role in the weight reducing effects of leptin treatment (2, 42, 47) . Changes in the rate of pre-adipocyte differentiation may or may not alter the proliferation rates of mature adipocytes, depending upon whether there is a change in the fate of new pre-adipocytes in vivo. The effect of leptin on proliferation of mature adipose cells has not been determined in vivo. The effects of leptin deficiency or caloric restriction on adipocyte proliferation have also not been directly measured.
While many biochemical studies in ob/ob mice have reported increased lipogenesis, gene expression micro array data has painted a different picture of adipose tissue dynamics in ob/ob mice (32, 37) and obese humans (8) . Expression of mRNAs for lipogenic enzymes (e.g. fatty acid synthase {FAS}, ATP citrate lyase, phophoenolpyruvate carboxykinase {PEP-CK}) and sterol response element-binding protein 1-c {SREBP-1c} were reported to be reduced, not elevated, in adipose tissue of ob/ob mice (32) . Paradoxically, treatment of ob/ob and lean mice with exogenous leptin further reduced the expression of similar sets of such lipogenic genes (32) . Based on these gene expression results, the authors (31) reasonably suggested that adipose tissue in ob/ob mice operates as if in a functionally replete state, with reduced capacity for lipid anabolism and storage. According to this model, adipose tissue function in ob/ob mice is analogous to a lipotrophic state, rather than an avidly lipid anabolic milieu. It is important to resolve these apparently discordant models of obesity suggested by gene expression versus flux measurements.
Reduced expression of lipogenic genes has also been reported in human obesity (8) . Increased hepatic DNL fluxes were measured with stable isotopes, yet there was reduced adipose lipogenic gene expression, perhaps secondary to increased circulating leptin levels (8) , providing further evidence of a functionally lipoatrophic state in obesity.
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Here, we compare lipogenic fluxes in vivo and gene expression in the same tissue (adipose). One of our objectives was to establish the independent effects of leptin and calorie intake. Accordingly, a low dose of leptin (2 µg/ day) was administered, as this dose has previously been shown to reduce food intake but not plasma insulin levels (17) .
Also, caloric restriction of ob/ob mice results in gorging or a "meal" feeding pattern,
followed by a prolonged fast, which may by itself affect DNL when compared to ad libitum feeding. We therefore controlled the pace of food intake in the food restricted ob/ob mice by using an automatic pellet dispenser to administer food at a fixed rate over each 24 hour period.
We show here that in the C57/BL6J lep/lep-(ob/ob) genetic model of obesity, fluxes through lipogenic and adipogenic pathways in adipose tissue are markedly elevated and that gene expression is not necessarily reflective of flux though these lipid anabolic pathways.
Methods

Animals:
Stable isotope studies: All animal experiments were performed in compliance with the UC Berkeley animal care and use committee. Six to seven week old, female, C57/BL6J mice (Jackson Labs, Bar Harbor, MI) were studied: C57/BL6J +n controls (ctrl), ad libitum fed C57/BL6J lep/lep-(ob/ob), leptin treated ob/ob (ob-lep) and food restricted ob/ob (ob-r). The rationale for studying ob-lep and ob-r was to determine whether changes in adipose tissue dynamics in ob/ob are driven by excess food intake or leptin deficiency per se. Mice were housed individually in hanging wire cages and fed AIN 93 purified diets Food for the ob-r group was administered in a continuous manner with automatic pellet dispensers (Coulbourn Instruments, Allentown PA). Food intake was set at 2.8 g/day, which represents the lower range of intake for lean mice, partially adjusting for the reduced total energy expenditure in ob/ob (4, 27, 36) . This ensured that sufficient caloric restriction was achieved for comparison to the effects of leptin administration (which also reduces food intake, see below).
Ob-lep mice received murine leptin (a gift from Amgen, Thousand Oaks, CA)
subcutaneously at a dose of 2µg/day via a 28 day Alzet mini osmotic pump (Alza Corp.
Palo Alto CA). This dose has previously been shown to achieve near physiologic leptin concentrations in ob/ob mice (17 
Blood measurements
At the end of the 3-week study period, blood was collected by cardiac puncture and placed on ice until plasma was separated and frozen. Plasma glucose concentrations were measured on a YSI (Yellow Springs, OH) auto analyzer. Plasma insulin and leptin assays were performed by assay services at Linco research (St. Charles, MO).
Changes in fat pad weight
The gain in weight of each fat pad was compared to the net synthesis of TG. Samples were spun at 800 rpm for 10 minutes. The adipocyte enriched, stromal-vascular cell depleted fraction was then carefully removed and frozen.
Bone marrow cells were isolated from the hind limb femur as described previously (33) .
DNA isolation and derivatization from adipose cells
The frozen slurry enriched in adipocytes was lyophilized and the dry weight of the sample was determined. The samples were digested and DNA was isolated as described elsewhere (33) using Qiagen DNeasy tissue kits. The yield of DNA from each sample was determined with a Pharmacia Biotec Genequant II spectrophotometer.
Ten to 25µg of DNA was hydrolyzed to free deoxyribonucleic acids, as described in detail elsewhere (33) . Isolated deoxyadenosine was reduced and the deoxyribose (dR) moiety was acetylated, as described previously (33) . The resulting pentose-tetraacetate (PTA) derivative of dR was injected in ethyl acetate into the GC/MS for measurement of isotope enrichments.
Derivatization and analysis of TG, FA and body water
Samples of adipose TG were taken following the incubation with collagenase and transesterified by incubation with 3N methanolic HCL (Sigma-Aldrich). Fatty acid (FA) methyl esters were separated from glycerol by Folch extraction. The phase containing free glycerol was then lyophilized and the glycerol was converted to glycerol tri-acetate by incubation with acetic anhydride -pyridine, 2:1, as described elsewhere (21) . The phase containing FA-methyl esters was concentrated under nitrogen and injected directly into the GC/MS.
2 H 2 O enrichments in body water were measured in tetrabromoethylene derivatized from plasma samples as described in detail elsewhere (7) . 
GC/MS analyses
RNA isolation and reverse transcription.
Total RNA was extracted using TRIzol Reagent (Invitrogen, Carlsbad CA ) and purified using RNeasy (Qiagen Inc, Valencia, CA). During purification, an on-column DNase I digestion step was carried out as described in the RNeasy Mini Protocol. 500ng
of total RNA from each sample and 2ug of total RNA pooled from each sample from the control group were reverse transcribed with random hexamers using TaqMan Reverse
Transcription Reagents (Applied Biosystems Foster City, CA).
Real-time PCR.
Real-time PCR was performed in 96-well format using the ABI Prism 7900HT sequence detection system and analyzed using SDS 2.0 software (Applied Biosystems).
For each gene transcript, 10ng of cDNA from each sample was analyzed as an unknown against a standard curve derived from a 5-fold dilution series of cDNA reverse transcribed from RNA pooled from the control group. Each 25ul PCR reaction was carried out using TaqMan Universal PCR Master Mix (Applied Biosystems) and primer and probe sets from Applied Biosystems Assays on Demand. Relative mRNA levels for each gene were measured in arbitrary units and normalized to GAPDH levels.
Calculations
TG synthesis
The fraction (f) of TG newly synthesized during the labeling period in an adipose depot was calculated based on the precursor-product relationship, as described previously (44, 20) , using the measured body water enrichment to estimate the maximal or asymptotic enrichment in TG-glycerol. The absolute rate of retained TG synthesis was calculated by multiplying f times the TG mass present at the time of measurement.
Estimate of net lipolysis
Net lipolysis was calculated as described previously (44):
Net lipolysis (mg/kg/21 days) = Absolute TG synthesized -Absolute TG accumulated.
In the case of the leptin treated mice, in which TG retained was a negative value (i.e.
body fat was lost) the absolute TG synthesis rate was added to the quantity of TG lost to yield the net lipolysis rat (i.e., the negative number was subtracted).
De Novo Lipogenesis (DNL)
Fractional DNL was calculated from the incorporation of 2 H into TG-palmitate, using mass isotopomer distribution analysis (MIDA) as described in detail elsewhere (39) . 
Adipose cell proliferation (adipogenesis)
Fractional adipose cell proliferation (f) was calculated as the EM 1 in adipose DNA divided by EM 1 in bone marrow DNA, as described in detail elsewhere (33) . Bone marrow DNA enrichment is used to approximate the maximum DNA enrichment achievable within each animal at the body water enrichment present (33) . The absolute adipose cell proliferation rate was estimated by multiplying f times total DNA yield from the tissue, and converting to cell numbers (assuming ~10 µg DNA/ 106 cells).
Statistical analysis
Data are presented as mean ± SD unless otherwise stated. Significance was determined by one way ANOVA followed with Tukey's pair wise comparisons. P< 0.05 was considered significant.
Results
Food Intake
Food intake in the control mice was 3.1 ± 0.4 grams per day. Food intake of the food-restricted ob/ob mice (ob-r) was fixed at 2.8 grams per day. Ob/ob mice consumed 5.1 ± 1.1 grams per day and the leptin treated ob/ob mice (ob-lep) ate 3.8 ± 0.9 grams per day. Significant differences were present between ob/ob and controls, ob-lep and ob-r (p<0.05) ( Table 1) .
Body weight
The effects of leptin treatment and food restriction on body weight during the 2 H 2 O labeling period are shown (Figure 1 ). Leptin treatment reduced body weight significantly more than food restriction, despite higher food intake in the leptin treated group.
Plasma insulin, glucose and leptin concentrations
Plasma insulin, glucose and leptin levels we measured from the terminal blood collection after a 4 hour fast in all groups at the end of the study. Insulin concentrations were significantly higher in all ob/ob groups, including the leptin treated group, compared to control mice, as has been previously reported (15) ( Table 1) . Plasma glucose concentrations were significantly higher in the ob/ob group compared to controls (Table 1) . Both food restriction and leptin treatment tended to reduce plasma glucose concentration in ob/ob mice, but only the leptin-treated group showed significant reductions compared to ob/ob. Plasma leptin levels in the leptin treated ob/ob and control mice were similar (5.7 ±2.9 ng/ml and 4.1 ±1.9 ng/ml, respectively, Table 1 ). In the ob/ob and food restricted ob/ob mice plasma leptin concentrations were undetectable.
Body fat distribution
The untreated ob/ob animals had larger fat pads (Table 2 ) which represented a higher percent of total body weight compared to controls. Food restriction significantly reduced the weight of all fat pads and leptin treatment resulted in a significantly greater weight reduction in inguinal and mesenteric pads.
Absolute rates of TG synthesis (all-source lipogenesis)
The absolute TG synthesis rate was markedly elevated in the ob/ob and food restricted ob/ob mice compared to control and leptin treated mice ( Figure 2 ). Leptin treatment also significantly reduced the fraction (f) of newly synthesized TG (Table 3a) compared to ob/ob, for each fat pad.
DNL contribution to adipose TG-palmitate
The contribution from DNL to newly synthesized TG-palmitate is shown in Table   3b . In the ob/ob and control mice, the DNL fractional contribution to newly deposited adipose TG was close to 100%. The leptin treated group exhibited a substantial reduction in the contribution from DNL to new TG. Food restriction also lowered the DNL contribution to newly synthesized TG, compared to ob/ob and controls.
Absolute rate of DNL
The absolute rate of DNL (grams palmitate synthesized de novo over the 21 day labeling period) was significantly elevated in the ob/ob group compared to controls ( Figure 3) . Food restriction had a small (non-significant) impact on absolute DNL.
Leptin treatment, in contrast, reduced absolute DNL to levels equal to or below those seen in the control mice in all depots.
Net lipolysis
Ob/ob mice had higher rates of net lipolysis (calculated as TG synthesis minus fat accumulated over 21 days) than the controls (Figure 4 
Adipogenesis
The absolute rate of adipose cell proliferation (adipogenesis) was markedly increased in the perimetrial and retroperitoneal fat pads of ob/ob mice compared to controls ( Figure 5 ). Leptin treatment, but not food restriction, markedly reduced adipose tissue cell proliferation in all fat pads, compared to ob/ob mice.
Gene expression
Expression levels of GPAT, SREBP1, DGAT1, GLUT4, FABP4, PEPCK, ACAT1 and PPAR-gamma were not elevated in ob/ob compared to controls (Figure 6 ), confirming previously reported micro array results (32, 37) . Notably, the expression of PEPCK, ACAT1 and FABP4 were reduced, while only DGAT2 and FAS expression were significantly elevated in ob/ob compared to controls. Interestingly, leptin treatment increased PEPCK and GLUT4 expression and FAS expression also trended upward with leptin treatment, whereas DGAT2 expression was no longer significantly elevated after leptin treatment. Most mRNA levels studied were not significantly altered by leptin administration.
Discussion
Leptin provides a signal from the adipose tissue to the central nervous system and other organs that regulates energy intake, energy expenditure and nutrient partitioning (11, (15) (16) (17) . Here, we show in vivo that this endocrine signal completes a full circle back to the adipose tissue, inducing dramatic effects on adipose lipid dynamics and cell proliferation, independent of food intake or insulin concentrations. Of perhaps equal interest, the measured changes in flux through lipid anabolic pathways in ob/ob versus lean control mice, or in response to leptin administration, were not generally reflected by adipose tissue mRNA levels. We found that leptin administration to ob/ob mice reduced rates of total TG synthesis ( Figure 2 ) and stimulated lipolysis (Figure 4 ), in vivo, consistent with previous studies (12, 30, 45) . Our data that clearly show that leptin deficiency, independent of hyperphagia or hyperinsulinemia, results in markedly increased lipogenic fluxes in ob/ob mice, consistent with reported in vitro (30) and in vivo (47) (Table 1) , a higher value than we previously estimated based on short term labeling studies in rodents, which measured primarily hepatic DNL (24) . DNL, therefore, makes a quantitatively substantial contribution to the accrual of adipose fat in rodents on chow diets and this pathway is stimulated in the ob/ob mouse. In humans, by contrast, DNL contributes about 20% of newly synthesized adipose TG-palmitate (39).
Of note, leptin suppressed adipose TG synthesis and DNL without significantly reducing plasma insulin concentrations. The dose of leptin (2 µg/d ) was selected to alter body weight but not plasma insulin levels, based on the work of Harris et al. (17) . The reduction in food intake with leptin treatment was also less than was achieved by food restriction alone, but leptin administration reduced lipogenic fluxes to a much greater extent than was observed with food restriction. Thus, leptin deficiency, independent of hyperphagia or hyperinsulinemia, results in major alterations in flux through lipid anabolic pathways in adipose tissue.
In addition to the inhibition of adipose cell proliferation rates reported here, leptin has been shown to have inhibitory or stimulatory effects on the proliferation of numerous This disparity between mRNA levels and the flow of molecules in vivo though complex pathways is instructive (18, 19, 43) . Considerable work from the field of metabolic engineering has led to the conclusion that, even in systems as simple as bacteria, manipulating gene expression does not typically alter metabolic flux distributions in a predictable manner within complex pathways and metabolic networks. In summary, these results emphasize the general rule, often ignored, that gene expression data should be interpreted cautiously with regard to functional outputs of complex pathways (10, 18, 19, 43) . . Quantitative RT-PCR of lipogenic genes in c57bl/6 mice (control, n = 5), ob/ob mice (n = 5), and ob/ob mice administered leptin (n = 5). Total RNA was isolated from inguinal adipose tissue and reverse transcribed. 10 ng of cDNA was used in each PCR reaction. Relative mRNA levels for each gene were normalized to an internal standard, GAPDH, and are expressed as this ratio. Data are expressed as mean ± SE. For each gene, one way repeated measures ANOVA was used to test for significant differences between the three groups. If groups differed significantly, pairwise comparisons were performed and p values were calculated using the Holm-Sidak method. Statistical analysis was done using SigmaStat 3.0. *, p<0.05 compared to control; †, p<0.01 compared to control; ‡, p<0.05 compared to ob/ob. GPAT, mitochondrial glycerol-3-phosphate acyltransferase; SREBP1, sterol regulatory element-binding protein 1; FAS, fatty acyl synthase; DGAT1, diacylglycerol O-acyltransferase 1; DGAT2, diacylglycerol O-acyltransferase 2; Glut4, solute carrier family 2 (facilitated glucose transporter), member 4; FABP4, adipocyte fatty acid binding protein 4; PEPCK, cytosolic phosphoenolpyruvate-carboxykinase 1; leptin, leptin; ACAT1, acetylCoenzyme A acetyltransferase 1; PPAR , peroxisome proliferator activator receptor gamma; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. 
